Patent · US Active

Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)

US7662927B2 · kind B2 · utility

7Cited by
13References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2008
Grant dateFeb 16, 2010
Priority date
Expiry dateAug 29, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to polynucleotide and polypeptide molecules for zcyto20, zcyto21, zcyto22, zycto24, and zcyto25 proteins which are most closely related to interferon-α at the amino acid sequence level. The receptor for this protein family is a class II cytokine receptor. The present invention includes methods of reducing viral infections and increasing monocyte counts. The present invention also includes antibodies to the zcyto20 polypeptides, and methods of producing the polynucleotides and polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.